�ٺ���Ƶ

News from �ٺ���Ƶ Health

Moody’s Upgrades �ٺ���Ƶ Health. (Becker's Hospital Review)

(1/22) reports, “Moody’s has upgraded New York City-based �ٺ���Ƶ Health revenue bonds from ‘A2’ to ‘A1,’” reflecting an “expected continuation of very strong and consistent operating performance and revenue growth relative to peers,’ driven by its strong market position and ‘highly effective and disciplined leadership.’” In a statement, �ٺ���Ƶ Health said that reinvestment permitted it to “sustain that high quality care, ensuring positive financial performance and continued exceptional healthcare outcomes.” The system said, “This includes our investment in hospitals like �ٺ���Ƶ Hospital-Brooklyn, which went from one of the worst in the nation, according to a 2017 Leapfrog study, to today – following our merger – becoming the only hospital in the borough with a Leapfrog A-rating and posting one of the lowest mortality rates in the nation.” 
Also reporting are (1/22), (1/22), and Bloomberg. 

American Academy of Pediatrics Recommends GLP-1 Drugs for Obese Teens. (WNBC-TV New York)

(1/22) Natalie E. Azar, MD, clinical associate professor, Department of Medicine, Division of Rheumatology of �ٺ���Ƶ Health discusses the recent recommendation of the American Academy of Pediatrics for the use of GLP-1 agonist drugs for obese teens older than the age of 12. 

Adam Pearson Speaks Out Against How Actors with Disabilities Are Only Offered Certain Types of Roles: ‘Lazy Writing’. (People)

(1/22) “Neurofibromatosis 1 affects about 100,000 people throughout the United States, and only a few million in the world, Kaleb H. Yohay, MD, professor, Departments of Neurology, and Pediatrics, Comprehensive Neurofibromatosis Center, previously told PEOPLE.”

2024 Clinical Preview for Epilepsy and Seizure Disorders: Claude Steriade, MD, CM. (Neurology Times)

(1/22) “Claude Steriade, MD, CM, associate professor, Department of Neurology, at NYU Grossman School of Medicine, recently sat down in an interview with NeurologyLive to share her clinical perspective on potential therapies in epilepsy and seizure disorders for 2024.”

Unlocking the Mystery of Unexpected Lucidity. (Northern Westchester (NY) Examiner)

The (1/22) “Sam Parnia, MD, PhD, associate professor, Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine at [�ٺ���Ƶ Health]” whose “groundbreaking research has helped monitor brain activity in people who are dying and clinically dead” and is now trying to record lucidity, or a brief period of mental clarity in those with dementia, often before death.

Can Dry January Cause Constipation? Here’s What Experts Say. (Verywell Health)

(1/22) “‘Alcohol impacts the gut in multiple ways,’ Rabia A. De Latour, MD, assistant professor, Department of Medicine, Division of Gastroenterology and Hepatology at �ٺ���Ƶ, told Verywell.”

Norovirus Alert: FDA Warns of Contaminated Raw Oysters from Mexico. (Fox News)

(1/22) “Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine at [�ٺ���Ƶ Health] and a Fox News medical contributor, pointed out that the biggest problem is that people tend to eat oysters raw, which leads to the highest amount of norovirus if contaminated.”

If You Donate DNA, What Should Scientists Give in Return? A ‘Pathbreaking’ New Model. (NPR)

(1/22) “Arthur L. Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor, Department of Population Health, Division of Medical Ethics at [NYU Grossman School of Medicine], says Handley’s” effort to inform and compensate human subjects when their DNA is collected for studies is “pathbreaking.”